Clinical Trial Update: Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating fecal microbiota transplantation for immune-checkpoint inhibitor–induced diarrhea or colitis in patients with genitourinary ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colitis
• Diarrhea
• Lung Cancer
• Malignant Genitourinary Neoplasms
• Melanoma
• Ovarian Cancer
• Uterine Cancer

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Colitis, Diarrhea | Phase 1 | Status: RECRUITING